Kamada Ltd (KMDA)

Price$7.70

Value ScoreC

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)0.99%

Price vs S&P 500 (4W)-9.84%

VGM Score52.11

Market Capitalization$450.53M

P/E Ratio (Annual)22.31x

Indicated Dividend Yield (Annual)3.20%

All Metrics

P/CF (Annual)17.67x

Book Value / Share (Quarterly)$4.50

P/TBV (Annual)2.35x

Indicated Dividend (Annual)$0.25

Revenue Growth (3Y)0.56%

Cash Flow / Share (Quarterly)$0.28

Price vs S&P 500 (YTD)-0.31%

Gross Margin (TTM)37.20%

Net Profit Margin (TTM)11.20%

EPS (TTM)$0.35

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$0.35

Revenue Growth (5Y)4.70%

EPS (Annual)$0.35

Dividend / Share (Annual)$0.20

ROI (Annual)7.20%

Gross Margin (Annual)38.94%

Net Profit Margin (5Y Avg)9.40%

Cash / Share (Quarterly)$1.27

P/E Basic Excl Extra (TTM)22.12x

Revenue Growth QoQ (YoY)2.82%

EPS Growth (5Y)-2.02%

P/E Normalized (Annual)22.31x

ROA (Last FY)5.33%

Revenue Growth TTM (YoY)31.34%

EBITD / Share (TTM)$0.69

ROE (5Y Avg)7.76%

Operating Margin (TTM)13.96%

Cash Flow / Share (Annual)$0.27

P/B Ratio1.74x

P/B Ratio (Quarterly)1.85x

Net Income / Employee (Annual)$51,400

EV / Revenue (TTM)2.54x

Net Interest Coverage (TTM)206.85x

ROA (TTM)5.41%

EPS Growth QoQ (YoY)0.72%

EV / EBITDA (TTM)11.40x

EPS Incl Extra (Annual)$0.35

Current Ratio (Annual)4.07x

Quick Ratio (Quarterly)1.90x

3-Month Avg Trading Volume0.06M

52-Week Price Return13.68%

EV / Free Cash Flow (Annual)29.54x

P/E Incl Extra (TTM)22.12x

Revenue / Employee (TTM)$462,900

Tangible BV / Share (Quarterly)$3.00

P/S Ratio (Annual)3.16x

Asset Turnover (Annual)0.40x

52-Week High$9.35

Operating Margin (5Y Avg)10.71%

EPS Excl Extra (Annual)$0.35

CapEx CAGR (5Y)-1.91%

Tangible BV CAGR (5Y)-20.17%

26-Week Price Return16.92%

Quick Ratio (Annual)2.21x

13-Week Price Return-12.35%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)3.33x

Enterprise Value$462.17M

Revenue / Share Growth (5Y)1.28%

Asset Turnover (TTM)0.48x

Book Value / Share Growth (5Y)12.05%

Revenue / Employee (Annual)$362,600

Inventory Turnover (Annual)1.14x

Pretax Margin (Annual)5.91%

Cash / Share (Annual)$1.31

3-Month Return Std Dev33.72%

Gross Margin (5Y Avg)35.50%

Net Income / Employee (TTM)$51,800

EBITDA CAGR (5Y)-2.82%

EBITDA Interim CAGR (5Y)11.20%

ROE (Last FY)7.51%

Net Interest Coverage (Annual)8.63x

EPS Basic Excl Extra (Annual)$0.35

P/FCF (TTM)151.21x

Receivables Turnover (TTM)6.17x

EV / Free Cash Flow (TTM)28.25x

Total Debt / Equity (Quarterly)0.04x

EPS Incl Extra (TTM)$0.35

Receivables Turnover (Annual)4.10x

ROI (TTM)7.41%

P/S Ratio (TTM)2.48x

Pretax Margin (5Y Avg)9.50%

Revenue / Share (Annual)$2.66

Tangible BV / Share (Annual)$3.00

Forward P/E15.52x

Free OCF CAGR (5Y)59.69%

Price vs S&P 500 (52W)-14.52%

P/E Ratio (TTM)22.12x

EPS Growth TTM (YoY)150.27%

Year-to-Date Return10.62%

5-Day Price Return-0.26%

EPS Normalized (Annual)$0.35

ROA (5Y Avg)5.37%

Net Profit Margin (Annual)5.81%

Month-to-Date Return-4.05%

Cash Flow / Share (TTM)$0.39

EBITD / Share (Annual)$0.48

Operating Margin (Annual)7.06%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)17.52x

ROI (5Y Avg)6.53%

P/E Excl Extra (TTM)22.12x

LT Debt / Equity (Quarterly)1.98x

EPS Basic Excl Extra (TTM)$0.35

P/TBV (Quarterly)2.35x

Payout Ratio (Annual)57.10%

P/B Ratio (Annual)1.51x

Dividend / Share (TTM)$0.22

Inventory Turnover (TTM)1.31x

Pretax Margin (TTM)12.23%

Book Value / Share (Annual)$4.66

Price vs S&P 500 (13W)-22.09%

Net Margin Growth (5Y)-2.71%

Dividend Yield (TTM)2.77%

Beta0.86x

P/FCF (Annual)28.80x

Revenue / Share (TTM)$3.08

ROE (TTM)7.73%

52-Week Low$6.50

vGradeC

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.07est. 0.12

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.22

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
KMDAKamada Ltd	C	C	C	$7.70
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
ABTAbbott Laboratories	C	C	D	$87.78
PFEPfizer Inc.	B	C	C	$25.63
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Kamada Ltd is a biopharmaceutical company that develops and markets plasma-derived protein therapeutics for specialty diseases across multiple therapeutic areas including hemophilia, lung disease, immunoglobulin deficiencies, vaccines, critical care, and diagnostics. The company's proprietary portfolio includes key products such as Glassia, Bramitob, Foster, and Ixiaro. Revenue is primarily generated from proprietary products, with a secondary distribution segment.